Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

56.33
Delayed Data
As of Mar 28
 -0.44 / -0.78%
Today’s Change
34.31
Today|||52-Week Range
67.74
+34.99%
Year-to-Date

Today’s Trading

Previous close56.77
Today’s open56.72
Day’s range56.14 - 58.00
Volume376,481
Average volume (3 months)724,214
Market cap$2.4B
Dividend yield--
Data as of 3:59pm ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)-60.95%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+18.22%
P/E ratioNM
Price/Sales23.36
Price/Book6.68

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC-0.43-2.90%
HCMHutchison China Medi...-0.07-0.36%
SAGESAGE Therapeutics In...-1.20-1.83%
ENDPEndo International P...+0.24+2.29%
Data as of 3:59pm ET, 03/28/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$1.80
Annual revenue (last year)$69.9M
Annual profit (last year)-$198.5M
Net profit margin-283.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Chief Financial Officer
Andrew J. Hirsch
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs